Sensitivity of GBM cells to cAMP agonist-mediated apoptosis correlates with CD44 expression and agonist resistance with MAPK signaling
Paul Daniel(Brigham and Women's Hospital), Theo Mantamadiotis(The Royal Melbourne Hospital)
Cited by 32
Related Papers
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
|Cancer Cell|2023|69
Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide
|Clinical Cancer Research|2019|58
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
|Journal of Clinical Investigation|2024|44